Absence or delayed anti‐HBc reactivity in patients with overt HBV infection has been associated with immunosuppression, HIV co‐infection, insufficient sensitivity of anti‐HBc assays and rare HBcAg variants.3, 4, 5, 6. The gene discussed is KRT88P; the disease is coinfection.